[English] 日本語
Yorodumi- PDB-8e1p: Crystal structure of BG505 SOSIP.v4.1-GT1.2 trimer in complex wit... -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 8e1p | ||||||
|---|---|---|---|---|---|---|---|
| Title | Crystal structure of BG505 SOSIP.v4.1-GT1.2 trimer in complex with gl-PGV20 and PGT124 Fabs | ||||||
Components |
| ||||||
Keywords | VIRAL PROTEIN/IMMUNE SYSTEM / HIV envelope glycoprotein / antibody / CD4 antibody / VIRAL PROTEIN-IMMUNE SYSTEM / VIRAL PROTEIN-IMMUNE SYSTEM complex | ||||||
| Function / homology | Function and homology informationpositive regulation of plasma membrane raft polarization / positive regulation of receptor clustering / host cell endosome membrane / clathrin-dependent endocytosis of virus by host cell / viral protein processing / fusion of virus membrane with host plasma membrane / fusion of virus membrane with host endosome membrane / viral envelope / virion attachment to host cell / host cell plasma membrane ...positive regulation of plasma membrane raft polarization / positive regulation of receptor clustering / host cell endosome membrane / clathrin-dependent endocytosis of virus by host cell / viral protein processing / fusion of virus membrane with host plasma membrane / fusion of virus membrane with host endosome membrane / viral envelope / virion attachment to host cell / host cell plasma membrane / virion membrane / structural molecule activity / identical protein binding / membrane Similarity search - Function | ||||||
| Biological species | Homo sapiens (human)![]() Human immunodeficiency virus 1 | ||||||
| Method | X-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 3.82 Å | ||||||
Authors | Sarkar, A. / Kumar, S. / Wilson, I.A. | ||||||
| Funding support | United States, 1items
| ||||||
Citation | Journal: Cell Rep Med / Year: 2023Title: Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertions. Authors: Caniels, T.G. / Medina-Ramirez, M. / Zhang, J. / Sarkar, A. / Kumar, S. / LaBranche, A. / Derking, R. / Allen, J.D. / Snitselaar, J.L. / Capella-Pujol, J. / Sanchez, I.D.M. / Yasmeen, A. / ...Authors: Caniels, T.G. / Medina-Ramirez, M. / Zhang, J. / Sarkar, A. / Kumar, S. / LaBranche, A. / Derking, R. / Allen, J.D. / Snitselaar, J.L. / Capella-Pujol, J. / Sanchez, I.D.M. / Yasmeen, A. / Diaz, M. / Aldon, Y. / Bijl, T.P.L. / Venkatayogi, S. / Martin Beem, J.S. / Newman, A. / Jiang, C. / Lee, W.H. / Pater, M. / Burger, J.A. / van Breemen, M.J. / de Taeye, S.W. / Rantalainen, K. / LaBranche, C. / Saunders, K.O. / Montefiori, D. / Ozorowski, G. / Ward, A.B. / Crispin, M. / Moore, J.P. / Klasse, P.J. / Haynes, B.F. / Wilson, I.A. / Wiehe, K. / Verkoczy, L. / Sanders, R.W. | ||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 8e1p.cif.gz | 991.4 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb8e1p.ent.gz | Display | PDB format | |
| PDBx/mmJSON format | 8e1p.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Summary document | 8e1p_validation.pdf.gz | 9 MB | Display | wwPDB validaton report |
|---|---|---|---|---|
| Full document | 8e1p_full_validation.pdf.gz | 9.2 MB | Display | |
| Data in XML | 8e1p_validation.xml.gz | 150.1 KB | Display | |
| Data in CIF | 8e1p_validation.cif.gz | 200.1 KB | Display | |
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/e1/8e1p ftp://data.pdbj.org/pub/pdb/validation_reports/e1/8e1p | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 5w6dS S: Starting model for refinement |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
-
Assembly
| Deposited unit | ![]()
| ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
| ||||||||||||
| Unit cell |
|
-
Components
-Protein , 2 types, 6 molecules EGMYXZ
| #5: Protein | Mass: 53394.711 Da / Num. of mol.: 3 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() Human immunodeficiency virus 1 / Production host: Homo sapiens (human)#7: Protein | Mass: 17146.482 Da / Num. of mol.: 3 / Fragment: UNP residues 509-661 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() Human immunodeficiency virus 1 / Gene: env / Production host: Homo sapiens (human) / References: UniProt: Q2N0S6 |
|---|
-Antibody , 5 types, 12 molecules FHNILOACJBDK
| #1: Antibody | Mass: 24399.408 Da / Num. of mol.: 3 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Production host: Homo sapiens (human)#2: Antibody | | Mass: 22229.459 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Production host: Homo sapiens (human)#3: Antibody | Mass: 22229.459 Da / Num. of mol.: 2 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Production host: Homo sapiens (human)#4: Antibody | Mass: 23056.605 Da / Num. of mol.: 3 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Production host: Homo sapiens (human)#6: Antibody | Mass: 25460.508 Da / Num. of mol.: 3 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Production host: Homo sapiens (human) |
|---|
-Sugars , 7 types, 47 molecules 
| #8: Polysaccharide | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta- ...beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Production host: Homo sapiens (human)#9: Polysaccharide | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Source method: isolated from a genetically manipulated source #10: Polysaccharide | alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D- ...alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose | Source method: isolated from a genetically manipulated source #11: Polysaccharide | alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D- ...alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose | Type: oligosaccharide / Mass: 1600.438 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source #12: Polysaccharide | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-beta-D- ...alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose | Source method: isolated from a genetically manipulated source #13: Polysaccharide | alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose | Source method: isolated from a genetically manipulated source #14: Sugar | ChemComp-NAG / |
|---|
-Details
| Has ligand of interest | Y |
|---|---|
| Has protein modification | Y |
-Experimental details
-Experiment
| Experiment | Method: X-RAY DIFFRACTION / Number of used crystals: 1 |
|---|
-
Sample preparation
| Crystal | Density Matthews: 3.58 Å3/Da / Density % sol: 65.63 % |
|---|---|
| Crystal grow | Temperature: 277.15 K / Method: vapor diffusion, sitting drop Details: 0.2 M ammonium sulfate, 0.1 M Tris, pH 8.5, 12% w/v PEG8000 |
-Data collection
| Diffraction | Mean temperature: 100 K / Serial crystal experiment: N |
|---|---|
| Diffraction source | Source: SYNCHROTRON / Site: APS / Beamline: 21-ID-D / Wavelength: 1.0332 Å |
| Detector | Type: DECTRIS PILATUS 6M / Detector: PIXEL / Date: Dec 2, 2017 |
| Radiation | Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray |
| Radiation wavelength | Wavelength: 1.0332 Å / Relative weight: 1 |
| Reflection | Resolution: 3.8→49.76 Å / Num. obs: 63948 / % possible obs: 95.7 % / Redundancy: 2.9 % / Biso Wilson estimate: 104.91 Å2 / CC1/2: 0.78 / Net I/σ(I): 4.3 |
| Reflection shell | Resolution: 3.82→3.88 Å / Num. unique obs: 5699 / CC1/2: 0.31 |
-
Processing
| Software |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Refinement | Method to determine structure: MOLECULAR REPLACEMENTStarting model: PDB entry 5W6D Resolution: 3.82→49.76 Å / SU ML: 0.6141 / Cross valid method: FREE R-VALUE / σ(F): 0.31 / Phase error: 31.5444 Stereochemistry target values: GeoStd + Monomer Library + CDL v1.2
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Solvent computation | Shrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å / Solvent model: FLAT BULK SOLVENT MODEL | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Displacement parameters | Biso mean: 122.39 Å2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement step | Cycle: LAST / Resolution: 3.82→49.76 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refine LS restraints |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LS refinement shell |
|
Movie
Controller
About Yorodumi



Homo sapiens (human)
Human immunodeficiency virus 1
X-RAY DIFFRACTION
United States, 1items
Citation
PDBj





